Biggest News Aggregation in the World
📰 Hoc Analyses News

Hoc Analyses News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Hoc Analyses. Real-time updates on events, politics, business and more.

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial | Coronavirus (COVID-19) | JAMA

This randomized clinical trial compares the effects of 3 doses of bamlanivimab monotherapy (700 vs 2800 vs 7000 mg) vs combination bamlanivimab and etesevimab v
United States Eteläuomen Läi Junshi Biosciences Bristol Myers Squibb Danielm Skovronsky Eli Lilly

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings

Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could potentially play in the treatment of hyperphosphatemia XPHOZAH consistently lowered serum... | April 12, 2023
United States Fosun Pharma Laura Williams Exchange Commission National Kidney Foundation Exchange Commission On

Takeda Pharmaceutical Company Limited: Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay

Data Include Exploratory Analysis Showing LIVTENCITY Treated Patients With Post-Transplant Cytomegalovirus (CMV) Infections/Disease Had Reductions in Hospitalizations (34.8%; p=0.021) and Length
United States Salt Lake City Barbara Alexander Jun Saito Clin Virol Erin Marie Beals

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science